An updated review on COVID-19

MA Ebada, A Wadaa-Allah, E Bahbah… - … Formerly Current Drug …, 2021 - ingentaconnect.com
Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …

[HTML][HTML] Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020

A Nabil, K Uto, MM Elshemy, R Soliman… - EXCLI …, 2020 - ncbi.nlm.nih.gov
Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and
positive-sense RNA genomes. In December 2019, an outbreak of coronavirus disease 2019 …

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

[HTML][HTML] Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

KL Hon, KKY Leung, AKC Leung, SY Qian… - Drugs in …, 2020 - ncbi.nlm.nih.gov
Many viral respiratory infections can cause severe acute respiratory symptoms leading to
mortality and morbidity. In the spring of 2003, the severe acute respiratory syndrome (SARS) …

Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19

D Verma, AK Yadav, N Chaudhary… - …, 2022 - ingentaconnect.com
A more focused approach is needed to understand the SARS-CoV-2 virulence, structure,
and genomics to devise more effective diagnostic and treatment interventions as this virus …

COVID‐19: a review of therapeutics under investigation

JC Crosby, MA Heimann, SL Burleson… - Journal of the …, 2020 - Wiley Online Library
The COVID‐19 outbreak has disrupted global health care networks and caused thousands
of deaths and an international economic downturn. Multiple drugs are being used on …

A focus on the nowadays potential antiviral strategies in early phase of coronavirus disease 2019 (Covid-19): A narrative review

C Monari, V Gentile, C Camaioni, G Marino, N Coppola… - Life, 2020 - mdpi.com
Background: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment

A Parasher - Postgraduate medical journal, 2021 - academic.oup.com
Background The severe acute respiratory syndrome (SARS) coronavirus-2 is a novel
coronavirus belonging to the family Coronaviridae and is now known to be responsible for …

[HTML][HTML] Therapeutic options for COVID-19: a review

R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …

[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows

F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …